PARP12 and breast carcinoma: Along with these roles, PARP12 has been identified as one of the main factors involved in the acquisition of breast-cancer resistance to chemotherapy, evidenced through a delayed cancer cell colony regrowth upon transcriptional inhibition of PARP12 [18].